PMC:7556165 / 47706-47923
Annnotations
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T239 | 87-97 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
| T240 | 87-91 | Species | denotes | SARS | NCBItxid:694009 |
| T241 | 135-145 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
| T242 | 135-139 | Species | denotes | SARS | NCBItxid:694009 |
| T243 | 169-177 | Species | denotes | SARS-CoV | NCBItxid:694009 |
| T244 | 169-173 | Species | denotes | SARS | NCBItxid:694009 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T294 | 0-217 | Sentence | denotes | The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020). |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1304 | 110-114 | Gene | denotes | ACE2 | Gene:59272 |
| 1314 | 87-97 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1315 | 135-145 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1316 | 169-177 | Species | denotes | SARS-CoV | Tax:694009 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T5182 | 110-114 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T190 | 128-133 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T383 | 128-133 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T219 | 87-97 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T220 | 87-91 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T221 | 135-145 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T222 | 135-139 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T223 | 169-177 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T224 | 169-173 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1304 | 110-114 | Gene | denotes | ACE2 | Gene:59272 |
| 1314 | 87-97 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1315 | 135-145 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1316 | 169-177 | Species | denotes | SARS-CoV | Tax:694009 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T294 | 0-217 | Sentence | denotes | The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020). |